<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/207</identifier>
				<datestamp>2024-10-30T19:15:47Z</datestamp>
				<setSpec>aavptbiennial:S5</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Ischemia-Reperfusion Injury: Role of Oxygen Radicals</dc:title>
	<dc:creator xml:lang="en">Korthuis, Ronald J.</dc:creator>
	<dc:subject xml:lang="en">oxygen radicals</dc:subject>
	<dc:subject xml:lang="en">ischemic tissues</dc:subject>
	<dc:subject xml:lang="en">hypoxanthine</dc:subject>
	<dc:subject xml:lang="en">free radicals</dc:subject>
	<dc:subject xml:lang="en">granulocyte adhesion</dc:subject>
	<dc:subject xml:lang="en">tissue injury</dc:subject>
	<dc:description xml:lang="en">Oxygen radicals appear to be produced upon reperfusion of ischemic tissues according to the following mechanism: During an ischemic period, xanthine dehydrogenase is converted to xanthine oxidase. Concomitantly, ATP is catabolized to hypoxanthine, which accumulates in the tissues. Upon reperfusion, molecular oxygen is reintroduced and reacts with hypoxanthine and xanthine oxidase to produce a burst of superoxide anion radicals and hydrogen peroxide with subsequent formation of hydroxyl radicals. These highly reactive and cytotoxic free radicals then cause tissue injury through lipid peroxidation of cell membranes, degradation of hyaluronic acid and possibly by promoting granulocyte adhesion and subsequent activation. The purpose of this review is to provide a description of the evidence in support of this hypothesis.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1986-06-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/207</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fifth Biennial Symposium; 209-220</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/207/197</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1986 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
